PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance
- PMID: 22907427
- DOI: 10.1038/onc.2012.361
PKA phosphorylation redirects ERα to promoters of a unique gene set to induce tamoxifen resistance
Abstract
Protein kinase A (PKA)-induced estrogen receptor alpha (ERα) phosphorylation at serine residue 305 (ERαS305-P) can induce tamoxifen (TAM) resistance in breast cancer. How this phospho-modification affects ERα specificity and translates into TAM resistance is unclear. Here, we show that S305-P modification of ERα reprograms the receptor, redirecting it to new transcriptional start sites, thus modulating the transcriptome. By altering the chromatin-binding pattern, Ser305 phosphorylation of ERα translates into a 26-gene expression classifier that identifies breast cancer patients with a poor disease outcome after TAM treatment. MYC-target genes and networks were significantly enriched in this gene classifier that includes a number of selective targets for ERαS305-P. The enhanced expression of MYC increased cell proliferation in the presence of TAM. We demonstrate that activation of the PKA signaling pathway alters the transcriptome by redirecting ERα to new transcriptional start sites, resulting in altered transcription and TAM resistance.
Similar articles
-
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.Breast Cancer Res Treat. 2015 Nov;154(2):225-37. doi: 10.1007/s10549-015-3609-7. Epub 2015 Oct 20. Breast Cancer Res Treat. 2015. PMID: 26487496 Free PMC article.
-
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.BMC Cancer. 2015 Aug 14;15:588. doi: 10.1186/s12885-015-1591-4. BMC Cancer. 2015. PMID: 26272591 Free PMC article.
-
OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.Oncogene. 2016 Nov 3;35(44):5722-5734. doi: 10.1038/onc.2016.105. Epub 2016 Apr 11. Oncogene. 2016. PMID: 27065334
-
Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.Maturitas. 2006 Jul 20;54(4):342-51. doi: 10.1016/j.maturitas.2006.06.003. Epub 2006 Jul 5. Maturitas. 2006. PMID: 16822624 Review.
-
Crosstalk of methylation and tamoxifen in breast cancer (Review).Mol Med Rep. 2024 Oct;30(4):180. doi: 10.3892/mmr.2024.13304. Epub 2024 Aug 12. Mol Med Rep. 2024. PMID: 39129315 Free PMC article. Review.
Cited by
-
Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Mol Endocrinol. 2015 Mar;29(3):349-63. doi: 10.1210/me.2014-1315. Epub 2015 Jan 27. Mol Endocrinol. 2015. PMID: 25625619 Free PMC article. Review.
-
Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways.Sci Rep. 2023 Nov 30;13(1):21163. doi: 10.1038/s41598-023-48198-y. Sci Rep. 2023. PMID: 38036593 Free PMC article.
-
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.Nat Commun. 2017 May 30;8:15427. doi: 10.1038/ncomms15427. Nat Commun. 2017. PMID: 28555617 Free PMC article.
-
Estrogen Receptor Alpha and ESR1 Mutations in Breast Cancer.Adv Exp Med Biol. 2022;1390:171-194. doi: 10.1007/978-3-031-11836-4_10. Adv Exp Med Biol. 2022. PMID: 36107319
-
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.Genome Biol. 2017 Oct 6;18(1):189. doi: 10.1186/s13059-017-1321-0. Genome Biol. 2017. PMID: 29017520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous